Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 23% ± 9% | |
capillary endothelial cell | 5 studies | 22% ± 8% |
Insufficient scRNA-seq data for expression of BCL6B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2403.58 | 458 / 459 | 96% | 13.21 | 1074 / 1118 |
thymus | 100% | 1954.92 | 653 / 653 | 93% | 14.37 | 562 / 605 |
lung | 100% | 4091.27 | 578 / 578 | 89% | 8.30 | 1030 / 1155 |
adrenal gland | 95% | 778.02 | 246 / 258 | 89% | 14.92 | 204 / 230 |
kidney | 98% | 1102.75 | 87 / 89 | 74% | 26.22 | 666 / 901 |
uterus | 99% | 1287.15 | 169 / 170 | 69% | 6.28 | 318 / 459 |
bladder | 95% | 1186.57 | 20 / 21 | 71% | 5.83 | 357 / 504 |
esophagus | 86% | 686.47 | 1239 / 1445 | 77% | 6.25 | 140 / 183 |
stomach | 82% | 476.90 | 293 / 359 | 80% | 7.93 | 229 / 286 |
intestine | 87% | 630.27 | 843 / 966 | 72% | 5.83 | 381 / 527 |
prostate | 89% | 690.82 | 217 / 245 | 71% | 4.79 | 355 / 502 |
brain | 49% | 250.31 | 1306 / 2642 | 86% | 7.32 | 605 / 705 |
pancreas | 38% | 171.63 | 126 / 328 | 96% | 13.25 | 171 / 178 |
skin | 63% | 403.92 | 1133 / 1809 | 68% | 5.46 | 319 / 472 |
liver | 40% | 179.85 | 91 / 226 | 85% | 7.30 | 347 / 406 |
ovary | 63% | 372.09 | 113 / 180 | 42% | 2.45 | 182 / 430 |
adipose | 100% | 2613.34 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1925.02 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 98% | 1250.29 | 848 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 6.59 | 39 / 45 |
muscle | 79% | 426.78 | 636 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 72% | 4.62 | 21 / 29 |
blood vessel | 68% | 535.36 | 910 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 20% | 0.86 | 16 / 80 |
peripheral blood | 0% | 1.47 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002682 | Biological process | regulation of immune system process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0001817 | Biological process | regulation of cytokine production |
GO_0005654 | Cellular component | nucleoplasm |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | BCL6B |
Protein name | BCL6B transcription repressor B-cell CLL/lymphoma 6 member B protein (Bcl6-associated zinc finger protein) (Zinc finger protein 62) B-cell CLL/lymphoma 6, member B (Zinc finger protein), isoform CRA_a (cDNA FLJ16548 fis, clone PLACE7000410, highly similar to B-cell CLL/lymphoma 6 member B protein) (cDNA FLJ77637) (cDNA FLJ77701, highly similar to Homo sapiens B-cell CLL/lymphoma 6, member B (zinc finger protein)(BCL6B), mRNA) |
Synonyms | ZNF62 BAZF hCG_32828 |
Description | FUNCTION: Acts as a sequence-specific transcriptional repressor in association with BCL6. May function in a narrow stage or be related to some events in the early B-cell development. . |
Accessions | Q8N143 ENST00000576705.1 A8KA13 ENST00000573503.1 ENST00000293805.10 ENST00000537931.2 I3L396 I3L304 H0YGW0 |